BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 23067691)

  • 1. [PET/CT scan with (18)F-FDG in re-staging of an atypical case of ovarian cancer].
    García Gómez FJ; Cuenca Cuenca JI; Acevedo Báñez I; Borrego Dorado I; Calvo García E; Vázquez Albertino RJ
    Rev Esp Med Nucl Imagen Mol; 2012; 31(4):223-4. PubMed ID: 23067691
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of 18F-FDG PET/CT in diagnosing peritoneal carcinomatosis in the restaging of patient with ovarian cancer as compared to contrast enhanced CT and tumor marker Ca-125.
    Rubini G; Altini C; Notaristefano A; Merenda N; Rubini D; Ianora AA; Asabella AN
    Rev Esp Med Nucl Imagen Mol; 2014; 33(1):22-7. PubMed ID: 23948509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolated adrenal metastasis of small cell neuroendocrine carcinoma of the ovary detected with FDG-PET/CT.
    Ozpacaci T; Tamam MO; Mulazimoglu M; Kamali G; Ozcan D
    Rev Esp Med Nucl Imagen Mol; 2012 Sep; 31(5):297-8. PubMed ID: 23067537
    [No Abstract]   [Full Text] [Related]  

  • 4. [18F]FDG-PET/CT monitoring early identifies advanced ovarian cancer patients who will benefit from prolonged neo-adjuvant chemotherapy.
    Martoni AA; Fanti S; Zamagni C; Rosati M; De Iaco P; D'Errico Grigioni A; Castellucci P; Quercia S; Musto A; Ricci Maccarini L; Lopci E; Bernardi A
    Q J Nucl Med Mol Imaging; 2011 Feb; 55(1):81-90. PubMed ID: 21068714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Staging and evaluation of neoadjuvant chemotherapy response with ¹⁸F-FDG PET/CT in NUT-midline carcinoma in a child: a case report and review of the literature.
    Ciftci E; Demirsoy U; Anik Y; Gorur G; Corapcioglu F; Demir H
    Rev Esp Med Nucl Imagen Mol; 2015; 34(1):53-5. PubMed ID: 25304847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative 18F-FDG PET/CT in the management of advanced epithelial ovarian cancer.
    Fruscio R; Sina F; Dolci C; Signorelli M; Crivellaro C; Dell'Anna T; Cuzzocrea M; Guerra L; Milani R; Messa C
    Gynecol Oncol; 2013 Dec; 131(3):689-93. PubMed ID: 24076062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. When and how often should PET scans be performed in the management of cervical cancer?
    Lai CH; Yen TC
    Expert Rev Anticancer Ther; 2010 Jul; 10(7):983-6. PubMed ID: 20645685
    [No Abstract]   [Full Text] [Related]  

  • 8. [Usefulness of 18F-FDG PET-CT in the presurgical assessment of malignant pleural mesothelioma treated with neoadjuvant chemotherapy].
    Orcajo Rincón J; Alonso Farto JC; Rotger Regi A; Hernández Pérez R; Hualde AM; Pérez Aradas V
    Rev Esp Med Nucl; 2011; 30(5):307-10. PubMed ID: 21641092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical impact of FDG-PET in patients with suspected recurrent ovarian cancer].
    Cuenca Cuenca JI; Borrego Dorado I; Vázquez Albertino R; Gómez Camarero P; Sanz Viedma S; Fernández López R
    Rev Esp Med Nucl; 2008; 27(6):411-7. PubMed ID: 19094899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FDG PET/CT of a benign ovarian Brenner tumor.
    Toriihara A; Taniguchi Y; Negi M; Kubota K; Makino T; Shibuya H
    Clin Imaging; 2012; 36(5):650-3. PubMed ID: 22920385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Peritoneal carcinomatosis from ovarian cancer: role of 18F-FDG-PET/CT and CA125].
    Rubini G; Altini C; Notaristefano A; Merenda N; Rubini D; Stabile Ianora AA; Giganti M; Niccoli Asabella A
    Recenti Prog Med; 2012 Nov; 103(11):510-4. PubMed ID: 23096741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lipomatous hypertrophy of the interatrial septum: findings in the (18)F-FDG PET/CT scan].
    García JR; Vollmer I; Soler M; Alvarez-Moro FJ; Fuertes S; Huguet M; Moragas M; Lomeña F
    Rev Esp Med Nucl; 2011; 30(6):382-3. PubMed ID: 21549451
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle.
    Mertens LS; Fioole-Bruining A; Vegt E; Vogel WV; van Rhijn BW; Horenblas S
    BJU Int; 2013 Oct; 112(6):729-34. PubMed ID: 23790129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [F-18-FDG positron emission tomography in the diagnosis of ovarian recurrence. Comparison with CT scan and CA 125].
    García Velloso MJ; Boán García JF; Villar Luque LM; Aramendía Beitia JM; López García G; Richter Echeverría JA
    Rev Esp Med Nucl; 2003; 22(4):217-23. PubMed ID: 12846945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential impact of 18F-FDG PET/CT on patients selection for neoadjuvant chemotherapy before radical cystectomy.
    Rouanne M; Girma A; Neuzillet Y; Vilain D; Radulescu C; Letang N; Yonneau L; Hervé JM; Botto H; Le Stanc E; Lebret T
    Eur J Surg Oncol; 2014 Dec; 40(12):1724-30. PubMed ID: 25242381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [PET/CT with (18F)FDG in the initial staging of a pelvic kidney neoplasm. A case report].
    Pifarré Montaner P; Simó Perdigó M; Plaza López P; Marco V; Alvarez Castells A; Martínez-Miralles E
    Rev Esp Med Nucl; 2009; 28(4):200-3. PubMed ID: 19922833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDG-PET/CT in advanced ovarian cancer staging: value and pitfalls in detecting lesions in different abdominal and pelvic quadrants compared with laparoscopy.
    De Iaco P; Musto A; Orazi L; Zamagni C; Rosati M; Allegri V; Cacciari N; Al-Nahhas A; Rubello D; Venturoli S; Fanti S
    Eur J Radiol; 2011 Nov; 80(2):e98-103. PubMed ID: 20688446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of FDG-PET/CT in ovarian cancer patients with high tumor markers or suspicious lesion on contrast-enhanced CT in evaluation of recurrence and/or in determination of intraabdominal metastases.
    Sari O; Kaya B; Kara PO; Gedik GK; Celik C; Ozbek O; Serdengecti M
    Rev Esp Med Nucl Imagen Mol; 2012; 31(1):3-8. PubMed ID: 21549452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual time point 2-deoxy-2-[18F]fluoro-D-glucose PET/CT: nodal staging in locally advanced breast cancer.
    García Vicente AM; Soriano Castrejón A; Cruz Mora MÁ; Ortega Ruiperez C; Espinosa Aunión R; León Martín A; González Ageitos A; Van Gómez López O
    Rev Esp Med Nucl Imagen Mol; 2014; 33(1):1-5. PubMed ID: 23707190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skin metastasis of ovarian cancer: a rare entity.
    Arslan C; Dede DS; Dizdar O; Altundag K
    J BUON; 2010; 15(2):398-9. PubMed ID: 20658746
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.